ZIRABEV 25 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 4 ML

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1211004740010
  • GGREM 522722050090607
  • Código de barras 7891045033183

O que a fonte publica

Detentor do registro
PFIZER BRASIL LTDA
Princípios ativos
BEVACIZUMABE
Embalagem
25 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 4 ML
Tipo de produto
Biológico
Classe terapêutica
L1G2 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, VEGF/VEGFR

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:522722050090607
{
  "name": "ZIRABEV 25 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 4 ML",
  "holder": "PFIZER BRASIL LTDA",
  "stripe": null,
  "barcodes": [
    "7891045033183"
  ],
  "confaz87": true,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "522722050090607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": true,
  "holderTaxId": "61.072.393/0001-33",
  "priceRegime": "Regulado",
  "productName": "ZIRABEV",
  "productType": "Biológico",
  "hospitalOnly": true,
  "presentation": "25 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 4 ML",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "1204.24",
    "icms-12": "1368.45",
    "icms-17": "1450.89",
    "icms-18": "1468.59",
    "icms-19": "1486.72",
    "icms-20": "1505.30",
    "icms-21": "1524.35",
    "icms-22": "1543.90",
    "icms-23": "1563.95",
    "icms-17.5": "1459.68",
    "icms-19.5": "1495.95",
    "icms-20.5": "1514.77",
    "icms-22.5": "1553.86",
    "icms-12-alc": "1352.03",
    "icms-17-alc": "1433.48",
    "icms-18-alc": "1450.96",
    "icms-19-alc": "1468.88",
    "icms-20-alc": "1487.24",
    "icms-21-alc": "1506.06",
    "icms-22-alc": "1525.37",
    "icms-23-alc": "1545.18",
    "withoutTaxes": "1189.79",
    "icms-17.5-alc": "1442.17",
    "icms-19.5-alc": "1478.00",
    "icms-20.5-alc": "1496.59",
    "icms-22.5-alc": "1535.21"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "BEVACIZUMABE",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [],
  "activeSubstances": [
    "BEVACIZUMABE"
  ],
  "therapeuticClass": "L1G2 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, VEGF/VEGFR",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1211004740010",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "L1G2",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:522722050090607"